Moderate aerobic exercise to manage menstrual symptoms
Official title: Impact of Moderate Aerobic Exercise on Menstrual Cycle Symptoms in Sedentary Women
Run by University of Colorado, Colorado Springs · NCT07084714 · Data updated 2026-11-12
This program will test whether a plan of moderate aerobic exercise can reduce physical and emotional menstrual symptoms in sedentary women who do or do not use hormonal birth control.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 35 (estimated) |
| Sponsor | University of Colorado, Colorado Springs Academic / other |
| Locations | 1 site (Colorado Springs, Colorado) |
| Status | Recruiting |
| Started | July 2025 |
| Main results expected | August 2026 |
| Study ends | August 2026 |
| Registry record updated | July 24, 2025 |
| Trial ID | NCT07084714 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Premenopausal sedentary women with regular menstrual cycles (every 21–35 days) who report menstrual symptoms and either have used combined oral contraceptives for at least six months or have not used hormonal contraception for at least six months.
✕Probably not a fit
Women who are pregnant or trying to conceive, have diabetes, cardiovascular, or renal disease, are already physically active, or cannot safely perform moderate exercise are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will enroll premenopausal, sedentary women who report menstrual symptoms and either have used combined oral contraceptives for at least six months or have not used hormonal contraception for at least six months. Participants will follow a moderate aerobic exercise intervention while reporting daily symptoms using the Menstrual Symptom Index, and body composition will be measured by DXA before and after the program. The study compares changes in physical and psychological symptom burden between hormonal contraceptive users and non-users to determine if contraceptive status modifies the effect of exercise. Primary outcomes include symptom score changes and body composition shifts associated with the intervention.
Why it matters
Potential benefit: If successful, the program could provide a non-drug option to reduce menstrual pain and other cycle-related symptoms for sedentary women.
How similar studies have gone: Prior research has shown that regular aerobic activity can reduce menstrual pain and premenstrual symptoms in some women, so this approach builds on existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * premenopausal (defined as having regular menstrual periods every 21-35 days) * either not using hormonal or non-hormonal contraceptives (i.e., intrauterine device) for the past 6 months OR using combined oral contraceptives (i.e., those that contain progesterone and estrogen) for at least the past 6 months * not currently pregnant or trying to become pregnant * sedentary lifestyle (score of "low activity/inactive" assessed using the IPAQ) * have self reported menstrual cycle symptoms (symptoms reported on the PSST or MSi) * do not have a medical diagnosis or signs/symptoms of diabetes, cardiovascular, or renal disease and are able to participate in moderate intensity physical activity without physician clearance Exclusion Criteria: * becoming physically active defined as scoring higher than "low activity/inactive" on the IPAQ during the first month of the study * non compliance with instructions provided for the moderate aerobic exercise intervention (i.e., not adhering to predetermined intensity heart rate targets) or miss more than 25% of exercise sessions in either intervention month * becoming pregnant during enrollment * being diagnosed with a cardiovascular, metabolic, or renal disease that would require physical clearance to participate in moderate intensity aerobic physical activity * begin using hormonal or non-hormonal (i.e., intrauterine devices) contraceptives if assigned to the arm not using hormonal contraceptives * either begin a different type of contraceptive or discontinue combined hormonal contraceptive use if assigned to the hormonal contraceptive arm
Where it's running
-
William J. Hybl Sports Medicine and Performance Center
Colorado Springs, Colorado, United States Recruiting
Study contacts
- Study coordinator: Marissa Baranauskas, PhD
- Email: mbaranau@uccs.edu
- Phone: 719-255-4475
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Menstrual cycle symptoms and female health
This study will observe how common menstrual symptoms and related conditions appear in young adult women who have regular periods, to better understand their frequency and impact.
-
Epigenetic markers linked to PMDD across the menstrual cycle
This study tests whether blood epigenetic markers can tell apart women with PMDD from women without PMDD at different points in the menstrual cycle.
-
Kaia Relief - Cycle System for Premenstrual Symptoms in Premenopausal Women
This trial tests whether the Kaia Relief - Cycle System can help reduce premenstrual symptoms and menstrual discomfort in healthy women aged 18–45 over about 12 weeks.
-
Pain and period life: does menstrual cycle or menopause change pain during root canals?
This study will see if pain during a root canal varies with menstrual cycle phase or menopausal status in adult patients.
-
Samphire Guided Care for Wellbeing at Work
This study tests a 12-week digital program with at-home neuromodulation to see if it helps women with menstrual or perimenopausal symptoms feel better at work and in daily life.
-
Somatic Movement Therapy vs Core Strengthening for PMS relief
This trial tests whether Somatic Movement Therapy or Core Strengthening Exercises better reduce PMS symptoms and improve stress and quality of life in young women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.